CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy CFO and Treasurer bought 100,000 shares at $15.96 ($1,596,470)
- 4 Shares withheld for taxes President and COO gave up 1,481 shares (to pay taxes)
- 4/A Shares withheld for taxes President and COO gave up 15,533 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 1,556 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 985 shares (to pay taxes)
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes CFO and Treasurer gave up 17,828 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 10,009 shares (to pay taxes)
- 4 Shares withheld for taxes President and COO gave up 17,356 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 47,354 shares (to pay taxes)
- 4 Shares withheld for taxes President and COO gave up 719 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,324 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 417 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 733 shares (to pay taxes)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 8 of 34 · 670 filings